Press Releases

23andMe Statement Regarding FDA Warning Letter

We have received the warning letter from the Food and Drug Administration. We recognize that we have not met the FDA’s expectations regarding timeline and communication regarding our submission. Our relationship with the FDA is extremely important to us and we are committed to fully engaging with them to address their concerns.



About 23andMe

23andMe, Inc. is the leading personal genetics company dedicated to helping people access, understand and benefit from the human genome. ‪Founded in 2006, the vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. More information is available at

Media Contact(s)

Kendra Brogden

Tracy Garcia
Return to top